Showing results (971-980 of 1,963) with videos related to

Sort By:
Pageof 197
RMD Open|September 23, 2026
Temporal evolution of synovial histopathology in rheumatoid arthritis across treatment periods: a large-scale analysis of 1770 surgical specimens using the Rooney scoreMasanori Sudo, Asami Abe, Hajime Ishikawa, et al.
RMD Open|November 3, 2022
Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapySilje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, et al.
RMD Open|November 3, 2022
Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and DenmarkAnne Emilie Pape Secher, Fredrik Granath, Bente Glintborg, et al.
RMD Open|November 3, 2022
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohortSimon Kuster, Suzana Jordan, Muriel Elhai, et al.
RMD Open|October 29, 2015
Belimumab in systemic lupus erythematosusAndreia Vilas-Boas, Sandra A Morais, David A Isenberg
RMD Open|October 29, 2015
Identifying patients with rheumatoid arthritis with moderate disease activity at risk of significant radiographic progression despite methotrexate treatmentB Fautrel, H W Nab, Y Brault, et al.
RMD Open|October 29, 2015
Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapyJohanna Callhoff, Katinka Albrecht, Georg Schett, et al.
RMD Open|October 29, 2015
Biological treatment in systemic juvenile idiopathic arthritis: achievement of inactive disease or clinical remission on a first, second or third biological agentA Woerner, F Uettwiller, I Melki, et al.
RMD Open|October 29, 2015
The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countriesA Finckh, D Neto, F Iannone, et al.
RMD Open|October 29, 2015
The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic regionX Mariette, J Vencovsky, O Lortholary, et al.
Pageof 197